| # | Drug | Count |
|---|---|---|
| 0 | ETONOGESTREL | 20 |
| 1 | VEDOLIZUMAB | 2 |
| 2 | ADALIMUMAB | 1 |
| 3 | CETIIRIZINE | 1 |
| 4 | CETIRIZINE | 1 |
| 5 | CETIRIZINE HYDROCHLORIDE | 1 |
| 6 | DROSPIRENONE AND ESTRADIOL | 1 |
| 7 | HUMAN C1-ESTERASE INHIBITOR | 1 |
| 8 | ORAL SEMAGLUTIDE | 1 |
| 9 | VANCOMYCIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DROSPIRENONE AND ESTRADIOL | 1 | 0.0019 |
| 1 | ETONOGESTREL | 20 | 0.0003 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 3 | HUMAN C1-ESTERASE INHIBITOR | 1 | 0.0001 |
| 4 | CETIIRIZINE | 1 | 0.0000 |
| 5 | VEDOLIZUMAB | 2 | 0.0000 |
| 6 | VANCOMYCIN | 1 | 0.0000 |
| 7 | ORAL SEMAGLUTIDE | 1 | 0.0000 |
| 8 | CETIRIZINE HYDROCHLORIDE | 1 | 0.0000 |
| 9 | ADALIMUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 21 |
| 1 | Integrin Receptor Antagonist [EPC] | 2 |
| 2 | Estrogen [EPC] | 1 |
| 3 | GLP-1 Receptor Agonist [EPC] | 1 |
| 4 | Glycopeptide Antibacterial [EPC] | 1 |
| 5 | Histamine-1 Receptor Antagonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin [EPC] | 21 | 0.0001 |
| 1 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 2 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Estrogen [EPC] | 1 | 0.0000 |
| 5 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |